Matthew Tarasek1, Jeannette Roberts2, Deirdre Cassidy 3, Thomas Foo1, Desmond Yeo1, Randall Carter2, and Brian Bales2
1MRI, GE Global Research, Niskayuna, NY, United States, 2Life Sciences, GE Global Research, Niskayuna, NY, United States, 3Life Sciences, GE Healthcare UK, United Kingdom, United Kingdom
Synopsis
Small animal scanning methods are common for
preclinical efficacy evaluation of contrast agents, and naïve animal studies
done on clinical scanners are becoming more prevalent. Unfortunately,
scanning small animals on large-bore clinical scanners creates several
challenges such as motion effects due to organ movement and very fast
heart-rates. Here we provide a retrospective motion-correction algorithm for
fast-heart-rate/free-breathing small animals based on diaphragm tracking.
Results show a ten-fold reduction in baseline contrast region signal
uncertainty and significant accuracy improvement of pharmacokinetic
time-constant estimation.
Purpose:
Contrast agents are used extensively in magnetic
resonance imaging (MRI) to identify areas of pathology in anatomical structures.1 Small animal scanning
methods are common for preclinical efficacy evaluation of these agents, and
naïve animal studies done on high-field clinical scanners are becoming more
prevalent.2,3 Unfortunately, scanning small animals on large-bore
clinical scanners creates several challenges. Some examples include reduced SNR,
motion effects due to organ movement and extremely fast animal heart-rate, and
body temperature control. Image gating to accommodate for a fast heart-rate
(>200 BPM) in small animals is very challenging without specialized
equipment and most gating methods for small animals result in major time
resolution reduction.4 Here we provide a retrospective
motion-correction algorithm is presented for fast-heart-rate/free-breathing
small animals based on diaphragm tracking. Results show a ten-fold reduction in
baseline contrast region signal uncertainty and significant accuracy
improvement of pharmacokinetic time-constant estimation with minimal reduction
in time-resolution.Methods:
Six
female Sprague Dawley rats were used in this for proof-of-concept study. Rats
were injected with 0.1 mmol/kg of a novel macrocyclic Mn-chelate. MR Imaging
tests were performed on a clinical 3T GE MR750 scanner (GE Healthcare, Waukesha, WI) using a rat-sized transmit/receive quadrature
Litz rat coil (Doty Scientific). Two sets of imaging data were acquired: (i)
pre-injection: acquired on the rats before
injection, and (ii) a 30-minute post-injection time series. During imaging,
rats were anaesthetized using isoflurane and core body temperature was
monitored by a calibrated fiber-optic rectal thermometer (SA Instruments, Stony
Brook NY). Multi-phase T1W data sets were acquired using 2D gradient
echo sequence with the following imaging parameters: FA = 30°,
TR = 6.2ms, TE = 1.9ms, FoV = 13cm2, matrix 256 x256, NEX = 1, full kidney
sagittal slice coverage, 4-5 mm thick, 300ms time resolution. The
post-processing algorithm was written in Matlab (Mathworks, Natick, MA) which
included the following steps: (i) Images were masked below the kidney and edge-detection
of the diaphragm was performed based on a Sobel approximation; in general, the method
returns edges at points where the gradient of the image intensity is maximum. (ii)
Three pairs of (x,y) points were extracted at different locations along the
bottom of the diaphragm (see Fig. 1c). For each fiducial point, the spatial
changes in S/I and A/P directions were vectorized (plot shown for visualization
in Fig.1a-b), and (iv) data was mapped for motion binning according to |DS/I – average(S/I)| as depicted in Fig.2. Time-resolved signal intensity
was analyzed in the kidney region pre-inject and post-contrast-inject, with and without motion correction binning results (Fig. 3a-d).
Pharmacokinetic evaluation was performed to evaluate the result of motion
correction on estimated rate constants, and to determine minimum binning edges
(visualized in Fig. 2 shaded region) for accurate curve fitting, i.e. fit R2
>0.9 (Fig. 4).Results:
The
plots in Fig. 1 a-b show the spatial changes in S/I and A/P directions for the
top (red) fiducial point in Fig. 1 right. In general, we see a 5+-fold greater
change in S/I than A/P directions for all fiducial point selections. In all
cases, data for S/I direction change from the top (red) fiducial point had the
greatest magnitude, and thus was used as primary input for motion binning. Results
of motion correction binning can be visualized in Fig. 3, and overall shows a
~10x reduction in pre-injection signal variation (Fig. 3 a-b), which leads to
large reduction in signal uncertainty for the full dynamic-contrast experiment (DCE)
as can be seen in Fig. 3 c-d. Selections for minimum binning edges were made by
optimizing for Pearson correlation coefficient (R2 > 0.9) of
curve fit to data. Results are shown in Fig. 4 and indicate a >66% change
between time-constants with and without motion correction.Discussion and Conclusion:
Results suggest that the most superior fiducial point
of the diaphragm provides the most substantial motion patterns dominated by S/I
position shifts. A motion-based data-binning of these S/I position shifts
provides robust accuracy improvement for pharmacokinetic rate constant
estimation in the rat kidney. Accuracy improvements were seen for all 6 rats
studied in this cohort. Further improvements are possible by incorporation of
A/P motion binning correction (in addition to S/I), although results indicate
that this will add <5% accuracy improvement in kidney DCE. Ongoing work will
look at liver and heart DCE results with both A/P and S/I motion binning. Acknowledgements
No acknowledgement found.References
[1] Caravan et al.
Chem. Rev., 99:2293-2352(1999) [2] Herrman et al. Mag Res Mater Phy 0284-5
(2011) [3] Yamamoto et al. Radiol Phys Technol. 2(1):13-21.
(2009) [4] Gilson et al. Methods, vol. 43, no. 1, pp. 35–45, (2007) [5] Tofts et al, MRM 17: 35767 (1991)